Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1/2 4Phase 1 4Phase 3 3Phase NA 1Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 8Glioma 7Breast Neoplasms 7Neoplasms 6Glioblastoma 6Pancreatic Neoplasms 5Neoplasm Metastasis 5Recurrence 4Lymphoma, B-Cell 4Lymphoma 4Brain Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Multiple Myeloma 3Melanoma 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Sarcoma 2Pancreatic Ductal Adenocarcinoma 2Myelodysplastic Syndromes 2Leukemia, Lymphocytic, Chronic, B-Cell 2Immunoglobulin Light-chain Amyloidosis 2Carcinoma, Transitional Cell 2Carcinoma, Squamous Cell 2Carcinoma, Hepatocellular 2Burkitt Lymphoma 2Advanced Solid Tumors 2Uterine Cervical Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Esophageal Squamous Cell Carcinoma × 30 days × Clear all
NCT06828588 2026-05-08

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Vanderbilt-Ingram Cancer Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
BreastGastrointestinal

Esophageal Squamous Cell Carcinoma, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡